RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 121 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131,693 | +2.1% | 121,938 | +22.0% | 0.00% | – |
| Q2 2023 | $128,968 | -15.0% | 99,976 | -13.0% | 0.00% | – |
| Q1 2023 | $151,749 | -23.7% | 114,962 | -13.3% | 0.00% | – |
| Q4 2022 | $198,851 | +275.2% | 132,567 | +195.0% | 0.00% | – |
| Q3 2022 | $53,000 | +1.9% | 44,943 | -2.6% | 0.00% | – |
| Q2 2022 | $52,000 | -65.8% | 46,140 | -8.9% | 0.00% | – |
| Q1 2022 | $152,000 | +16.0% | 50,639 | +2.3% | 0.00% | – |
| Q4 2021 | $131,000 | -48.0% | 49,509 | -28.7% | 0.00% | – |
| Q3 2021 | $252,000 | -12.5% | 69,397 | +4.6% | 0.00% | – |
| Q2 2021 | $288,000 | +12.9% | 66,328 | -11.2% | 0.00% | – |
| Q1 2021 | $255,000 | -6.6% | 74,691 | -4.1% | 0.00% | – |
| Q4 2020 | $273,000 | -47.9% | 77,919 | -64.3% | 0.00% | – |
| Q3 2020 | $524,000 | +94.8% | 218,290 | +48.2% | 0.00% | – |
| Q2 2020 | $269,000 | +263.5% | 147,317 | +211.3% | 0.00% | – |
| Q1 2020 | $74,000 | -27.5% | 47,324 | -1.1% | 0.00% | – |
| Q4 2019 | $102,000 | +7.4% | 47,828 | -5.6% | 0.00% | – |
| Q3 2019 | $95,000 | -20.2% | 50,650 | +10.9% | 0.00% | – |
| Q2 2019 | $119,000 | -1.7% | 45,688 | -3.1% | 0.00% | – |
| Q1 2019 | $121,000 | +11.0% | 47,173 | -0.2% | 0.00% | – |
| Q4 2018 | $109,000 | -35.1% | 47,272 | -9.7% | 0.00% | – |
| Q3 2018 | $168,000 | +29.2% | 52,347 | +14.2% | 0.00% | – |
| Q2 2018 | $130,000 | +80.6% | 45,847 | +124.9% | 0.00% | – |
| Q1 2018 | $72,000 | -2.7% | 20,381 | +6.3% | 0.00% | – |
| Q4 2017 | $74,000 | +51.0% | 19,181 | 0.0% | 0.00% | – |
| Q3 2017 | $49,000 | -21.0% | 19,181 | -15.2% | 0.00% | – |
| Q2 2017 | $62,000 | -13.9% | 22,626 | +4.1% | 0.00% | – |
| Q1 2017 | $72,000 | +67.4% | 21,743 | +20.2% | 0.00% | – |
| Q4 2016 | $43,000 | -29.5% | 18,084 | +8.9% | 0.00% | – |
| Q3 2016 | $61,000 | +64.9% | 16,601 | 0.0% | 0.00% | – |
| Q2 2016 | $37,000 | +19.4% | 16,601 | +10.8% | 0.00% | – |
| Q1 2016 | $31,000 | -31.1% | 14,978 | 0.0% | 0.00% | – |
| Q4 2015 | $45,000 | +21.6% | 14,978 | 0.0% | 0.00% | – |
| Q3 2015 | $37,000 | -51.3% | 14,978 | -37.1% | 0.00% | – |
| Q2 2015 | $76,000 | +33.3% | 23,831 | -19.0% | 0.00% | – |
| Q3 2014 | $57,000 | -57.5% | 29,411 | -26.7% | 0.00% | – |
| Q2 2013 | $134,000 | – | 40,107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |